Blood Pressure Levels, Prevalence, and Innovative Approaches to Prevent Arterial Hypertension in Adolescent and Young Adult Populations
DOI:
https://doi.org/10.51699/ijhsms.v4i1.196Keywords:
Blood pressure, Adolescents, Youth, Hypertension, LifestyleAbstract
This study examines blood pressure characteristics in adolescents and young adults, specifically students from Andijan State Medical Institute, to assess factors influencing blood pressure levels and the prevalence of arterial hypertension. Background: Hypertension in youth poses significant health risks, yet determinants in this age group remain understudied. Objective: To identify lifestyle and genetic influences on blood pressure in adolescents and young adults. Methods: Blood pressure was monitored daily, complemented by questionnaires on participants' physical activity, diet, and family history. Results reveal that both lifestyle habits and hereditary factors substantially impact blood pressure. These findings support the development of targeted prevention strategies to reduce hypertension risk in this population.
References
A. V. Kontsevaya, Y. A. Balanova, A. E. Imaeva, et al., "Economic Damage from Hypercholesterolemia at the Population Level in the Russian Federation," Rational Pharmacotherapy in Cardiology, vol. 14, no. 3, pp. 394–400, 2018. DOI: https://doi.org/10.20996/1819-6446-2018-14-3-393-401
I. V. Leontieva, "Familial Homozygous Hypercholesterolemia in Children: Strategy of Early Diagnosis and Treatment," Russian Journal of Perinatology and Pediatrics, vol. 66, no. 4, pp. 118–127, 2021, doi: https://doi.org/10.21508/1027-4065-2021-66-4-118-128. DOI: https://doi.org/10.21508/1027-4065-2021-66-4-118-128
S. Parve, A. Chaudhari, and A. V. Sineglazova, "Prevalence of Risk Factors of Chronic Non-Infectious Diseases Among Foreign Students of Kazan," Prophylactic Medicine, no. 5, p. 53, 2020.
D. I. Sadykova and I. Ya. Lutfullin, "Primary Arterial Hypertension and Myocardial Hypertrophy in Childhood and Adolescence," Pediatrics: Journal Named After G. N. Speransky, vol. 88, no. 5, pp. 17–20, 2009.
D. I. Sadykova, K. R. Salakhova, L. F. Galimova, E. S. Slastnikova, et al., "Familial Hypercholesterolemia in Children: Current State of the Problem," Voprosy Sovremennoi Pediatrii, vol. 22, no. 3, pp. 231–239, 2023. DOI: https://doi.org/10.15690/vsp.v22i3.2576
U. V. Chubochkina, M. V. Ezhov, T. A. Rozhkova, et al., "Five-Year Follow-Up of Patients with Homo- and Heterozygous Familial Hypercholesterolemia in the RENESSANCE Registry," Atherosclerosis and Dyslipidemia, no. 1, pp. 5–18, 2023, doi: https://doi.org/10.34687/2219-8202.JAD.2023.01.0001. DOI: https://doi.org/10.34687/2219-8202.JAD.2023.01.0001
"Cardiovascular Diseases," World Health Organization: Official Website. Available online: https://www.who.int/health-topics/cardiovascular-diseases (accessed Apr. 12, 2023).
G. G. Main and A. M. Siahtieva, "Secondary Hyperlipidemia: Definition, Phenotypes, and Inducing Factors," International Journal of Heart and Vascular Diseases, vol. 9, no. 32, p. 43–51, 2021.
N. Thonglang, R. Sukmawen, E. B. Lianes, and Z. V. Lee, "Dyslipidemia Management for Primary Prevention of Cardiovascular Events: Best Clinical Practices," Preventive Medicine Reports, vol. 27, p. 101819, 2022, doi: https://doi.org/10.1016/j.pmedr.2022.101819. DOI: https://doi.org/10.1016/j.pmedr.2022.101819
G. P. Rossi, et al., "Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy with Treatment of Primary Aldosteronism," Hypertension, vol. 62, no. 1, pp. 62–69, 2013. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.113.01316
D. Pewsner, et al., "Accuracy of Electrocardiography in Diagnosis of Left Ventricular Hypertrophy in Arterial Hypertension: Systematic Review," BMJ, vol. 335, no. 7622, p. 711, 2007. DOI: https://doi.org/10.1136/bmj.39276.636354.AE
S. T. U. Rich and B. H. Brundage, "High-Dose Calcium Channel-Blocking Therapy for Primary Pulmonary Hypertension: Evidence for Long-Term Reduction in Pulmonary Arterial Pressure and Regression of Right Ventricular Hypertrophy," Circulation, vol. 76, no. 1, pp. 135–141, 1987. DOI: https://doi.org/10.1161/01.CIR.76.1.135
J. Gomez-Arroyo, et al., "Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension," Circulation: Heart Failure, vol. 6, no. 1, pp. 136–144, 2013. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.111.966127
G. Kopec, et al., "Electrocardiogram for the Diagnosis of Right Ventricular Hypertrophy and Dilation in Idiopathic Pulmonary Arterial Hypertension," Circulation Journal, vol. 76, no. 7, pp. 1744–1749, 2012. DOI: https://doi.org/10.1253/circj.CJ-11-1517
M. B. Kolli, et al., "Cerium Oxide Nanoparticles Attenuate Monocrotaline-Induced Right Ventricular Hypertrophy Following Pulmonary Arterial Hypertension," Biomaterials, vol. 35, no. 37, pp. 9951–9962, 2014. DOI: https://doi.org/10.1016/j.biomaterials.2014.08.037
S. Reitzinger, M. Reiss, and T. Czypionka, "Costs Attributable to Hypercholesterolemia in a Single Period and Over the Life Cycle," The European Journal of Health Economics, 2024, pp. 1–9. DOI: https://doi.org/10.1007/s10198-024-01684-0
O. V. Fatenkov, Y. A. Panisheva, and M. A. Galkina, "Pharmacoeconomics of Treatment for Patients with High-Level Hypercholesterolemia," Science and Innovations in Medicine, vol. 4, no. 1, pp. 26–31, 2019. DOI: https://doi.org/10.35693/2500-1388-2019-4-1-26-31
A. V. Khera, et al., "Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients with Severe Hypercholesterolemia," Journal of the American College of Cardiology, vol. 67, no. 22, pp. 2578–2589, 2016. DOI: https://doi.org/10.1016/j.jacc.2016.03.520
T. van der Weijden, et al., "Economic Evaluation of Cholesterol-Related Interventions in General Practice: An Appraisal of the Evidence," Journal of Epidemiology & Community Health, vol. 52, no. 9, pp. 586–594, 1998. DOI: https://doi.org/10.1136/jech.52.9.586
I. K. Luirink, et al., "The Clinical and Molecular Diversity of Homozygous Familial Hypercholesterolemia in Children: Results from the GeneTics of Clinical Homozygous Hypercholesterolemia (GoTCHA) Study," Journal of Clinical Lipidology, vol. 13, no. 2, pp. 272–278, 2019. DOI: https://doi.org/10.1016/j.jacl.2018.12.003
M. J. Varghese, "Familial Hypercholesterolemia: A Review," Annals of Pediatric Cardiology, vol. 7, no. 2, pp. 107–117, 2014. DOI: https://doi.org/10.4103/0974-2069.132478
M. P. McGowan, et al., "Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia," Journal of the American Heart Association, vol. 8, no. 24, p. e013225, 2019. DOI: https://doi.org/10.1161/JAHA.119.013225
A. Nohara, et al., "Homozygous Familial Hypercholesterolemia," Journal of Atherosclerosis and Thrombosis, vol. 28, no. 7, pp. 665–678, 2021.
F. Mainieri, V. M. Tagi, and F. Chiarelli, "Recent Advances on Familial Hypercholesterolemia in Children and Adolescents," Biomedicines, vol. 10, no. 5, p. 1043, 2022. DOI: https://doi.org/10.3390/biomedicines10051043
P. Chelladurai, et al., "Targeting Histone Acetylation in Pulmonary Hypertension and Right Ventricular Hypertrophy," British Journal of Pharmacology, vol. 178, no. 1, pp. 54–71, 2021. DOI: https://doi.org/10.1111/bph.14932
